[ 1 ] Walt G. Who’s world health report 2003[J]. BMJ, 2004, 328(7430): 6.
[2]
[ 2 ] Diez-Tejedor E, Fuentes B. Acute care in stroke: The importance of early intervention to achieve better brain protection[J]. Cerebrovasc Dis, 2004, 17 (Suppl 1): 130-137.
[3]
[ 3 ] Baird AE, Austin MC, McKay WJ, et al. Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: Relation to clinical outcome[J]. J Neurol Neurosurg Psychiatry, 1996, 61(1): 26-29.
[4]
[ 4 ] Albright KC, Schott TC, Jafari N, et al. Tissue plasminogen activator use: Evaluation and initial management of ischemic stroke from an iowa hospital perspective[J]. J Stroke Cerebrovasc Dis, 2005, 14(3): 127-135.
[5]
[ 5 ] Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, american heart association[J]. Circulation, 1996, 94(5): 1167-1174.
[6]
[ 6 ] Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: A review of the risk factors[J]. Cerebrovasc Dis, 2007, 24(1): 1-10.
[7]
[ 7 ] Perini F, De Boni A, Marcon M, et al. Systolic blood pressure contributes to intracerebral haemorrhage after thrombolysis for ischemic stroke[J]. J Neurol Sci, 2010, 297(1-2): 52-54.
[8]
[ 8 ] Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the american heart association/american stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: The american academy of neurology affirms the value of this guideline as an educational tool for neurologists[J]. Circulation, 2007, 115(20): 478-534.
[9]
[ 9 ] Tsivgoulis G, Frey JL, Flaster M, et al. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage[J]. Stroke, 2009, 40(11): 3631-3634.
[10]
Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: Pooled analysis of atlantis, ecass, and ninds rt-pa stroke trials[J]. Lancet, 2004, 363(9411): 768-774.
[11]
Derex L, Hermier M, Adeleine P, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator[J]. J Neurol Neurosurg Psychiatry, 2005, 76(1): 70-75.
[12]
Gilligan AK, Markus R, Read S, et al. Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke[J]. Stroke, 2002, 33(9): 2236-2242.
[13]
Harrington C. Managing hypertension in patients with stroke. Are you prepared for labetalol infusion[J]. Crit Care Nurse, 2003, 23(3): 30-38.
Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the ninds rt-pa stroke trial[J]. Stroke, 1998, 29(8): 1504-1509.
[16]
Martin-Schild S, Hallevi H, Albright KC, et al. Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke[J]. Arch Neurol, 2008, 65(9): 1174-1178.
[17]
Ahmed N, Wahlgren N, Brainin M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (sits-istr) [J]. Stroke, 2009, 40(7): 2442-2449.
[18]
Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator[J]. Stroke, 2002, 33(8):2066-2071.
[19]
Molina CA, Alexandrov AV, Demchuk AM, et al. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator[J]. Stroke, 2004, 35(1): 151-156.
[20]
Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial doppler predicts the response to intravenous thrombolysis for stroke[J]. Stroke, 2007, 38(3): 948-954.
[21]
Delgado-Mederos R, Ribo M, Rovira A, et al. Prognostic significance of blood pressure variability after thrombolysis in acute stroke[J]. Neurology, 2008, 71(8): 552-558.
[22]
Molina CA, Barreto AD, Tsivgoulis G, et al. Transcranial ultrasound in clinical sonothrombolysis (tucson) trial[J]. Ann Neurol, 2009, 66(1): 28-38.
[23]
Ibrahim MM, Sebastian J, Hussain M, et al. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke[J]. Cerebrovasc Dis, 2010, 30(5): 508-513.
[24]
Delgado MG, Michel P, Naves M, et al. Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population[J]. J Neurol Neurosurg Psychiatry, 2010, 81(3): 282-285.
[25]
Saqqur M, Tsivgoulis G, Molina CA, et al. Symptomatic intracerebral hemorrhage and recanalization after iv rt-pa: A multicenter study[J]. Neurology, 2008, 71(17): 1304-1312.
[26]
Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: Prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume[J]. Stroke, 2002, 33(8): 2047-2052.
[27]
Christou I, Alexandrov AV, Burgin WS, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke[J]. Stroke, 2000, 31(8): 1812-1816.
[28]
Tsivgoulis G, Saqqur M, Sharma VK, et al. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke[J]. Stroke, 2007, 38(3): 961-966.
[29]
Takada T, Yasaka M, Minematsu K, et al. Predictors of clinical outcome in patients receiving local intra-arterial thrombolysis without subsequent symptomatic intracranial hemorrhage against acute middle cerebral artery occlusion[J]. AJNR Am J Neuroradiol, 2004, 25(10): 1796-1801.
[30]
Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke[J]. N Engl J Med, 2004, 351(21): 2170-2178.
[31]
Latchaw RE, Alberts MJ, Lev MH, et al. Recommendations for imaging of acute ischemic stroke: A scientific statement from the american heart association[J]. Stroke, 2009, 40(11): 3646-3678.
[32]
Alexandrov AV, Demchuk AM, Wein TH, et al. Yield of transcranial doppler in acute cerebral ischemia[J]. Stroke, 1999, 30(8): 1604-1609.
[33]
Chernyshev OY, Garami Z, Calleja S, et al. Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia[J]. Stroke, 2005, 36(1): 32-37.
[34]
Dharmasaroja PA, Dharmasaroja P, Muengtaweepongsa S. Outcomes of thai patients with acute ischemic stroke after intravenous thrombolysis[J]. J Neurol Sci, 2011, 300(1-2): 74-77.
[35]
Lindsberg PJ, Soinne L, Roine RO, et al. Community-based thrombolytic therapy of acute ischemic stroke in helsinki[J]. Stroke, 2003, 34(6): 1443-1449.
[36]
Alexandrov AV, Demchuk AM, Felberg RA, et al. High rate of complete recanalization and dramatic clinical recovery during tpa infusion when continuously monitored with 2-mhz transcranial doppler monitoring[J]. Stroke, 2000, 31(3): 610-614.
